Search

Search Constraints

You searched for: Author/Creator Luo, M

Search Results

1. DOP051 Shorter disease duration is associated with higher response rates to vedolizumab in Crohn's disease but not ulcerative colitis: a multi-centre consortium analysis. (16th January 2018)

2. DOP053 Impact of concomitant immunomodulator use on vedolizumab effectiveness: a multicentre consortium propensity score-matched analysis. (16th January 2018)

6. Isotope effect on zonal flow and its configuration dependence in low-density electron-cyclotron-resonance heated plasmas in Heliotron J. (27th August 2021)

8. P419 Clinical effectiveness and safety of first-line biologic vedolizumab as a monotherapy or combination therapy in ulcerative colitis and Crohn's disease patients: results from the EVOLVE study. (15th January 2020)